Overview

This trial is active, not recruiting.

Condition stage 1 hypertension
Treatments milk peptides and plant sterols, placebo
Phase phase 3
Sponsor Valio Ltd
Collaborator Helsinki University
Trial identifier NCT01031485, Valio-70

Summary

The purpose of this study is to investigate the effects of bioactive milk peptides on blood pressure in mildly hypertensive subjects.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking double-blind
Arm
(Active Comparator)
milk peptides and plant sterols
(Placebo Comparator)
placebo

Primary Outcomes

Measure
Blood pressure
time frame:

Eligibility Criteria

Male or female participants from 30 years up to 60 years old.

Inclusion Criteria: - age 30-60 years - systolic blood pressure 140-160 mmHg and diastolic blood pressure 90-99 mmHg in office measurement - apparently healthy Exclusion Criteria: - antihypertensive and lipid-lowering drugs - unstable coronary artery disease, diabetes, malignant diseases, secondary hypertension - BMI > 32 kg/m2 - milk allergy - smoking - alcohol abuse - pregnancy, lactation - simultaneous participation in other clinical trial

Trial information was received from ClinicalTrials.gov and was last updated in December 2009.
Information provided to ClinicalTrials.gov by Valio Ltd.